TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
POU5F1 |
Q01860
|
POU class 5 homeobox 1
|
|
0.95 |
0.441 |
0.846 |
MICA |
Q29983
|
MHC class I polypeptide-related sequence A
|
|
5.0E-03 |
0.473 |
0.846 |
DDR1 |
Q08345
|
discoidin domain receptor tyrosine kinase 1
|
Kinase
|
4.6E-06 |
0.497 |
0.808 |
CCHCR1 |
Q8TD31
|
coiled-coil alpha-helical rod protein 1
|
|
1.0E-16 |
0.505 |
0.808 |
TAP2 |
Q03519
|
transporter 2, ATP binding cassette subfamily B member
|
Transporter
|
6.9E-11 |
0.517 |
0.808 |
AIF1 |
P55008
|
allograft inflammatory factor 1
|
Calcium-binding protein
|
1.9E-06 |
0.521 |
0.808 |
CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
GRM5 |
P41594
|
glutamate metabotropic receptor 5
|
G-protein coupled receptor
|
1.00 |
0.525 |
0.846 |
NOTCH4 |
Q99466
|
notch receptor 4
|
|
2.1E-23 |
0.534 |
0.731 |
LTB |
Q06643
|
lymphotoxin beta
|
Signaling
|
9.6E-11 |
0.555 |
0.769 |
TNXB |
P22105
|
tenascin XB
|
|
1.9E-02 |
0.572 |
0.731 |
MICB |
Q29980
|
MHC class I polypeptide-related sequence B
|
|
4.1E-05 |
0.576 |
0.731 |
CDSN |
Q15517
|
corneodesmosin
|
|
0.46 |
0.585 |
0.731 |
HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
SKIV2L |
Q15477
|
Ski2 like RNA helicase
|
|
1.3E-22 |
0.615 |
0.654 |
C2 |
P06681
|
complement C2
|
|
1.3E-16 |
0.617 |
0.692 |
TRIM31 |
Q9BZY9
|
tripartite motif containing 31
|
|
4.3E-06 |
0.626 |
0.577 |
TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
TSBP1 |
Q5SRN2
|
testis expressed basic protein 1
|
|
1.5E-16 |
0.638 |
0.692 |
DDX39B |
Q13838
|
DExD-box helicase 39B
|
|
1.00 |
0.641 |
0.808 |
ZNRD1 |
Q9P1U0
|
zinc ribbon domain containing 1
|
|
0.21 |
0.653 |
0.654 |
PSORS1C1 |
Q9UIG5
|
psoriasis susceptibility 1 candidate 1
|
|
2.7E-04 |
0.656 |
0.731 |